@article{KrausGlassmannGolletzetal.2021,
  author    = {Dominik Kraus and Alexander Glassmann and Carsten Golletz and Glen Kristiansen and Jochen Winter and Rainer Probstmeier},
  title     = {Zona Pellucida Protein 2 (ZP2) Is Expressed in Colon Cancer and Promotes Cell Proliferation},
  series   = {Cancers},
  volume    = {13},
  number    = {8},
  publisher = {MDPI},
  address   = {Basel},
  issn      = {2072-6694},
  doi       = {10.3390/cancers13081759},
  url       = {https://nbn-resolving.org/urn:nbn:de:hbz:1044-opus-53783},
  year      = {2021},
  abstract  = {Our study shows ZP2 to be a new biomarker for diagnosis, best used in combination with other low abundant genes in colon cancer. Furthermore, ZP2 promotes cell proliferation via the ERK1/2-cyclinD1-signaling pathway. We demonstrate that ZP2 mRNA is expressed in a low-abundant manner with high specificity in subsets of cancer cell lines representing different cancer subtypes and also in a significant proportion of primary colon cancers. The potential benefit of ZP2 as a biomarker is discussed. In the second part of our study, the function of ZP2 in cancerogenesis has been analyzed. Since ZP2 shows an enhanced transcript level in colon cancer cells, siRNA experiments have been performed to verify the potential role of ZP2 in cell proliferation. Based on these data, ZP2 might serve as a new target molecule for cancer diagnosis and treatment in respective cancer types such as colon cancer.},
  language  = {en}
}